Ignite Creation Date:
2025-12-24 @ 11:59 AM
Ignite Modification Date:
2026-03-18 @ 4:47 AM
Study NCT ID:
NCT03990961
Status:
COMPLETED
Last Update Posted:
2024-09-19
First Post:
2019-06-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab for Patients With PD-L1 Diffuse Large B Cell Lymphoma (DLBCL)
Sponsor:
Organization: